CTRI/2020/09/027922尚未招募未知
Evaluation of serum HE4 , CA125 and Risk Of Ovarian Malignancy Algorithm(ROMA)for diagnosis of ovarian malignancy
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients of any age group with complex adnexal mass
排除标准
- •1. Pregnant females
- •2. Known cases of genital malignancy
- •3. Previously treated for ovarian malignancy
- •4. Known cases of endometriosis or pelvic
- •tuberculosis
研究者
相似试验
Unknown
不适用
The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerOvarian NeoplasmsNCT02687321Brno University Hospital150
已完成
不适用
Ovarian Cancer Risk Estimation in Patients With Pelvic MassAdnexal MassOvarian CancerNCT00987649Fujirebio Diagnostics, Inc.512
已完成
不适用
Evaluation of HE4 and CA125 serum markers to improve the risk determination of ovarian cancer in Malaysian womeMalignant neoplasm of ovaryCancerOvarian cancerISRCTN45238573Abbott Laboratories (Singapore)600
已完成
不适用
HE4 as a Relapse Biomarker in Ovarian CancersOvarian CarcinomaNCT02595281Institut de Cancérologie de Lorraine90
已完成
不适用
Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancerendometriomaJPRN-UMIN000019369Obstetrics and Gynecology, Nagoya University School of Medicine40